Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

The prognostic value of tissue-type plasminogen activator (tPA) measured in samples derived from 865 patients with primary breast cancer using a recently developed enzyme-linked immunosorbent assay (ELISA) was evaluated. Since the assay could easily be adapted to the assessment of the complex of tPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Witte, J H de, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, Tienoven, ThH van, Heuvel, J J T M, Vries, J Bolt-De, Benraad, ThJ, Foekens, J A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362996/
https://www.ncbi.nlm.nih.gov/pubmed/10390010
http://dx.doi.org/10.1038/sj.bjc.6690353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362996/
https://www.ncbi.nlm.nih.gov/pubmed/10390010
http://dx.doi.org/10.1038/sj.bjc.6690353

Ejemplares similares